✦ LIBER ✦

O56 Efficacy of Diacerin (™Diasol) in patients with symptomatic OA knees: results from a 24 week open label study

✍ Scribed by M Saluja; VL Joshi; V Kunjeer; S Salvi; A Chopra

Book ID: 117689129
Publisher: Elsevier Science
Year: 2008
Tongue: English
Weight: 69 KB
Volume: 3
Category: Article
ISSN: 0973-3698
DOI: 10.1016/s0973-3698(10)60430-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Risperidone in the treatment of mixed st

Risperidone in the treatment of mixed state bipolar patients: Results from a 24-week, multicenter, open-label study in Korea

✍ Young Sup Woo; Won-Myong Bahk; Duk-In Jon; Sang-Keun Chung; Sang-Yeol Lee; Yong 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 119 KB

Long-Term Safety and Efficacy of Donepez

Long-Term Safety and Efficacy of Donepezil in Patients with Dementia with Lewy Bodies: Results from a 52-Week, Open-Label, Multicenter Extension Study

✍ Ikeda, Manabu; Mori, Etsuro; Kosaka, Kenji; Iseki, Eizo; Hashimoto, Mamoru; Mats 📂 Article 📅 2013 🏛 S. Karger AG 🌐 English ⚖ 856 KB

Efficacy and safety of efalizumab for sc

Efficacy and safety of efalizumab for scalp psoriasis: Results from a prospective, 24-week, open-label phase IIIb/IV clinical trial in patients from Latin America

📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 50 KB

Efficacy of solifenacin in patients prev

Efficacy of solifenacin in patients previously treated with tolterodine extended release 4 mg: Results of a 12-week, multicenter, open-label, flexible-dose study

✍ Michael B. Chancellor; Norman Zinner; Kristene Whitmore; Kathleen Kobashi; Jeffr 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 171 KB

Demonstration of safety in Alzheimer's p

Demonstration of safety in Alzheimer's patients for intervention with an anti-hypertensive drug Nilvadipine: results from a 6-week open label study

✍ S. P. Kennelly; L. Abdullah; D. Paris; J. Parish; V. Mathura; M. Mullan; F. Craw 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 205 KB 👁 2 views

## Abstract ## Background Nilvadipine may lower rates of conversion from mild‐cognitive impairment to Alzheimer's disease (AD), in hypertensive patients. However, it remains to be determined whether treatment with nilvadipine is safe in AD patients, given the higher incidence of orthostatic hypote

P.4.006 Long-term efficacy and safety be

P.4.006 Long-term efficacy and safety benefits from treatment with the NMDA antagonist memantine: results of a 24-week, open-label extension study in moderate to severe Alzheimer's disease

✍ H.-J. Moebius; B. Reisberg; F. Schmitt; R. Doody 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 274 KB